• Info
  • Insider Ownership

Insider Trading & Ownership of Polly A. Murphy

Location
Boston, MA
Summary
The estimated net worth of Polly A. Murphy is at least $445,486 dollars as of 24 Jun 2025. Polly A. Murphy is the Director of Atea Pharmaceuticals, Inc. and owns shares of Atea Pharmaceuticals, Inc. (AVIR) stock worth about $360.2K. Polly A. Murphy is the Director of Celcuity Inc. and owns shares of Celcuity Inc. (CELC) stock worth about $85.3K.
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Polly A. Murphy
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Polly A. Murphy and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Polly A. Murphy has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $445,486.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Atea Pharmaceuticals, Inc. ($360,186).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Polly A. Murphy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AVIR Atea Pharmaceuticals, Inc. Director $360,186 20 Jun 2025
CELC Celcuity Inc. Director $85,300 19 May 2025

Insider Transactions Reported by Polly A. Murphy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored